TABLE 1.
Antibiotic susceptibility profiles for S. aureus isolatesa
| Drugb | MIC (μg/ml)/CLSI interpretationc |
||||||
|---|---|---|---|---|---|---|---|
| NRS1 | NRS70 | NRS71 | NRS123 | VRS1 | VRS2 | VRS3 | |
| VAN | 8/I | 0.5/S | 0.5/S | 1/S | >256/R | 64/R | >32/R |
| TEC | 8/S | 0.25/S | 0.5/S | 1/S | 64/R | 8/S | 16/I |
| CIP | 16/R | 0.5/S | >16/R | 0.5/S | >16/R | >16/R | >16/R |
| DAP | 2/NA | 0.5/NA | |||||
| CLI | >4/R | >4/R | 0.12/S | >4/R | >4/R | >4/R | |
| ERY | >8/R | >8/R | 0.5/S | >8/R | >8/R | >8/R | |
| GEN | >16/R | 1/S | 0.5/S | 0.5/S | >16/R | >16/R | >16/R |
| LNZ | 1/S | 1/S | 2/S | 2/S | 1/S | 2/S | |
| OXA | >32/R | >16/R | >16/R | >16/R | >16/R | >16/R | >16/R |
| PEN | >8/R | >2/R | >2/R | >2/R | >2/R | >2/R | >2/R |
| SYN | 0.12/S | 0.5/S | 1/S | 0.25/S | 0.5/S | 0.5/S | 0.5/S |
| TET | 32/R | 32/R | |||||
| SXT | ≤0.12/2.28/S | ≤0.25/4.75/S | ≤0.25/4.75/S | ≤0.25/4.75/S | 2/38/S | 1/19/S | 0.25/4.75/S |
a
Data taken from www.narsa.net.
b
Abbreviations of drugs: VAN, vancomycin; TEC, teicoplanin; CIP, ciprofloxacin; CLI, clindamycin; ERY, erythromycin; GEN, gentamicin; LNZ, linezolid; OXA, oxacillin; PEN, penicillin; SYN, quinupristin-dalfopristin; TET, tetracycline; SXT, trimethoprim-sulfamethoxazole.
c
S, susceptible; R, resistant; I, intermediate; NA, not available.